Regenerative Medicine to Cure Sickle Cell Anemia. Robert A. Brodsky, MD Johns Hopkins Family Professor of Medicine and Oncology Director: Division of Adult Hematology. Glossary of terms. BMT B one m arrow t ransplantation B lood or m arrow t ransplantation Stem cell transplantation
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Robert A. Brodsky, MD
Johns Hopkins Family Professor of Medicine and Oncology
Director: Division of Adult Hematology
Number of Transplants
SAFETY and Donor availability
Non-myeloablative or “mini” BMT
Matched sibs available <30% pts
The Holy Grail of BMT?
Szydloet al JCO 1997
Emadi, Jones and Brodsky. Nat Rev ClinOncol 2009
SCD kills an estimated half-million people worldwide annually.
"When one considers the additional contributions of sickle cell disease associated with
reduced quality of life, uncompensated care, lost productivity, and premature mortality,
the full burden of sickle cell disease is likely to be quite higher."
Kauf et al, Am J Hematol. 2009
with post-transplant Cyclophosphamide (CY)
ATG Day -9 to -7
Bolanos-Meade et al, Blood 2012
* Hgb reflects transfusion of RBCs within last 90 days